Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients

  • Protocol
  • Intervention

Authors

  • Anat Fisher,

    Corresponding author
    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada
    • Anat Fisher, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, V6T 1Z3, Canada. Anat.Fisher@ti.ubc.ca.

    Search for more papers by this author
  • Vijaya M Musini,

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada
    Search for more papers by this author
  • Ken Bassett

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the benefits and harms of antiviral treatments in adult patients with lamivudine-resistant chronic hepatitis B.